tiprankstipranks
Trending News
More News >
Kanoria Chemicals & Industries Ltd (IN:KANORICHEM)
:KANORICHEM
India Market
Advertisement

Kanoria Chemicals & Industries Ltd (KANORICHEM) AI Stock Analysis

Compare
0 Followers

Top Page

IN:KANORICHEM

Kanoria Chemicals & Industries Ltd

(KANORICHEM)

Rating:43Neutral
Price Target:
₹86.00
▼(-0.83% Downside)
Kanoria Chemicals & Industries Ltd's overall stock score is primarily influenced by its weak financial performance, marked by net losses and high leverage. Technical analysis indicates bearish momentum, while valuation concerns arise from a negative P/E ratio and lack of dividends. The absence of positive catalysts from earnings calls or corporate events leaves the stock with a moderate risk profile.

Kanoria Chemicals & Industries Ltd (KANORICHEM) vs. iShares MSCI India ETF (INDA)

Kanoria Chemicals & Industries Ltd Business Overview & Revenue Model

Company DescriptionKanoria Chemicals & Industries Ltd (KANORICHEM) is an Indian company engaged in the manufacturing and distribution of chemical products. The company operates in various sectors, including basic chemicals and specialty chemicals. Its core products include alcohol, formaldehyde, and derivatives, functioning as key inputs for industries such as textiles, pharmaceuticals, and resins.
How the Company Makes MoneyKanoria Chemicals & Industries Ltd generates revenue primarily through the production and sale of its chemical products. The company operates manufacturing facilities that produce a range of chemicals, which are then sold to various industries such as textiles, pharmaceuticals, automotive, and agriculture. Key revenue streams include the sale of formaldehyde, hexamine, phenolic resins, and other chemical derivatives. The company may also engage in strategic partnerships and collaborations to enhance its product offerings and expand its market reach. Additionally, fluctuations in raw material prices and foreign exchange rates can significantly impact the company's earnings.

Kanoria Chemicals & Industries Ltd Financial Statement Overview

Summary
Kanoria Chemicals & Industries Ltd faces financial challenges with fluctuating revenues, persistent net losses, and increasing debt levels. While there are signs of operational recovery, the company requires strategic management actions to enhance profitability, reduce leverage, and improve cash flows.
Income Statement
45
Neutral
Kanoria Chemicals & Industries Ltd shows fluctuating revenue with a recent decline from 2023 to 2024, followed by a slight increase in 2025. The gross profit margin has improved, yet the company has been experiencing net losses in recent years, with net income turning negative. This indicates challenges in cost management and profitability. The EBIT margin has been volatile and negative in 2024, but improved slightly in 2025, suggesting some operational recovery.
Balance Sheet
50
Neutral
The company maintains a moderate debt-to-equity ratio, increasing from previous years, which indicates a rise in leverage. The equity ratio is relatively stable, showing a consistent level of equity financing. However, declining stockholders' equity and increased debt levels pose a risk to financial stability. Return on equity has turned negative recently due to net losses, affecting investor returns.
Cash Flow
40
Negative
Free cash flow has been negative, indicating the company is facing challenges generating cash after capital expenditures. The operating cash flow to net income ratio suggests a reliance on non-operating activities for cash generation, as net income remains negative. The company needs to improve cash generation to support operations and reduce financial strain.
BreakdownMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Income Statement
Total Revenue15.37B14.55B15.78B13.69B10.95B
Gross Profit4.71B1.63B4.62B3.86B3.44B
EBITDA313.70M642.63M826.90M955.19M1.01B
Net Income-836.00M-383.96M-87.70M68.26M145.23M
Balance Sheet
Total Assets14.98B14.90B14.81B14.03B13.62B
Cash, Cash Equivalents and Short-Term Investments109.60M161.00M308.20M314.68M348.06M
Total Debt5.95B5.09B5.10B4.75B4.93B
Total Liabilities9.88B8.73B8.74B8.01B7.66B
Stockholders Equity5.21B6.01B6.05B5.98B5.87B
Cash Flow
Free Cash Flow-800.10M-432.20M-317.60M402.19M548.15M
Operating Cash Flow202.80M375.70M257.20M830.76M824.60M
Investing Cash Flow-648.70M-503.50M-249.80M-431.08M-118.15M
Financing Cash Flow414.60M51.40M-7.60M-530.48M-749.09M

Kanoria Chemicals & Industries Ltd Technical Analysis

Technical Analysis Sentiment
Negative
Last Price86.72
Price Trends
50DMA
92.82
Negative
100DMA
90.06
Negative
200DMA
99.97
Negative
Market Momentum
MACD
-1.27
Positive
RSI
39.55
Neutral
STOCH
20.46
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:KANORICHEM, the sentiment is Negative. The current price of 86.72 is below the 20-day moving average (MA) of 90.48, below the 50-day MA of 92.82, and below the 200-day MA of 99.97, indicating a bearish trend. The MACD of -1.27 indicates Positive momentum. The RSI at 39.55 is Neutral, neither overbought nor oversold. The STOCH value of 20.46 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:KANORICHEM.

Kanoria Chemicals & Industries Ltd Peers Comparison

Overall Rating
UnderperformOutperform
Sector (44)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
74
Outperform
₹5.50B67.18
2.99%45.21%
72
Outperform
₹1.76B17.88
68
Neutral
₹1.88B17.96
7.44%-76.65%-76.77%
49
Neutral
₹5.04B34.48
30.63%
44
Neutral
C$923.76M-8.68-0.23%2.69%24.53%-41.45%
43
Neutral
₹3.79B
10.07%-34.76%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IN:KANORICHEM
Kanoria Chemicals & Industries Ltd
85.61
-30.04
-25.97%
IN:CENTEXT
Century Extrusions Ltd
22.31
-3.13
-12.30%
IN:LORDSCHLO
Lords Chloro Alkali Limited
201.05
66.00
48.87%
IN:MAHASTEEL
Mahamaya Steel Industries Ltd.
345.95
227.65
192.43%
IN:OCCL
Oriental Carbon & Chemicals Ltd
189.80
-86.05
-31.19%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jul 26, 2025